Clinical Trial Update: Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating pembrolizumab in combination with nab-paclitaxel in non-small cell lung cancer has completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED